Rubbing my ball, page-1571

I remember reading a comment by LC that that was the preferred position of the company,

Preferences are in order, from memory anyway.
1. Imugene gets bought out.

2. Licensing Deals/Joint Ventures

3. Go it alone if they have to.

I still think option 2 is the most likely to occur. In some ways my preferred choice too. We get a boost to MC and subsequently SP and we then have a royalty deal giving income. If we get this across even 3 of the 5 Ip's things would be quite rosy.

A full takeover offer might undervalue true value.

I might be completely wrong here, it is however my view.

Up front payment and royalty deals on our 3 best, I think puts us at a $50B MC company

Not sure we would see that sort of money in a take over offer.